JPH04351961A - Fluorescent label-coloring matter, organism-derived material labeled tereby and reagent containing these - Google Patents
Fluorescent label-coloring matter, organism-derived material labeled tereby and reagent containing theseInfo
- Publication number
- JPH04351961A JPH04351961A JP12437291A JP12437291A JPH04351961A JP H04351961 A JPH04351961 A JP H04351961A JP 12437291 A JP12437291 A JP 12437291A JP 12437291 A JP12437291 A JP 12437291A JP H04351961 A JPH04351961 A JP H04351961A
- Authority
- JP
- Japan
- Prior art keywords
- group
- atom
- reagent
- compound
- fluorescent label
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 27
- 238000004040 coloring Methods 0.000 title abstract 4
- 239000000463 material Substances 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 claims abstract description 12
- 102000036639 antigens Human genes 0.000 claims abstract description 12
- 108091007433 antigens Proteins 0.000 claims abstract description 12
- 239000002773 nucleotide Substances 0.000 claims abstract description 10
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 9
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims description 28
- 125000005647 linker group Chemical group 0.000 claims description 14
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 239000000975 dye Substances 0.000 claims description 13
- 239000007850 fluorescent dye Substances 0.000 claims description 12
- 238000001215 fluorescent labelling Methods 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 108091034117 Oligonucleotide Proteins 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000002252 acyl group Chemical group 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 125000004437 phosphorous atom Chemical group 0.000 claims description 5
- 229910052710 silicon Inorganic materials 0.000 claims description 5
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 229910052718 tin Inorganic materials 0.000 claims description 4
- 229910052721 tungsten Inorganic materials 0.000 claims description 4
- 229910052725 zinc Inorganic materials 0.000 claims description 4
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 3
- OAKPWEUQDVLTCN-NKWVEPMBSA-N 2',3'-Dideoxyadenosine-5-triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO[P@@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)O1 OAKPWEUQDVLTCN-NKWVEPMBSA-N 0.000 claims description 3
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 3
- OTXOHOIOFJSIFX-POYBYMJQSA-N [[(2s,5r)-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(=O)O)CC[C@@H]1N1C(=O)NC(=O)C=C1 OTXOHOIOFJSIFX-POYBYMJQSA-N 0.000 claims description 3
- HDRRAMINWIWTNU-NTSWFWBYSA-N [[(2s,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1CC[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HDRRAMINWIWTNU-NTSWFWBYSA-N 0.000 claims description 3
- ARLKCWCREKRROD-POYBYMJQSA-N [[(2s,5r)-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 ARLKCWCREKRROD-POYBYMJQSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 229910052793 cadmium Inorganic materials 0.000 claims description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 108091033319 polynucleotide Proteins 0.000 claims description 3
- 239000002157 polynucleotide Substances 0.000 claims description 3
- 102000040430 polynucleotide Human genes 0.000 claims description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical group [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 2
- URGJWIFLBWJRMF-JGVFFNPUSA-N ddTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)CC1 URGJWIFLBWJRMF-JGVFFNPUSA-N 0.000 claims description 2
- 229910052733 gallium Inorganic materials 0.000 claims description 2
- 229910052732 germanium Inorganic materials 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 2
- 229910052711 selenium Inorganic materials 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- -1 antibodies Substances 0.000 abstract description 30
- 150000001875 compounds Chemical class 0.000 abstract description 26
- 230000010355 oscillation Effects 0.000 abstract description 10
- 239000004065 semiconductor Substances 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000003018 immunoassay Methods 0.000 description 4
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 3
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000011135 tin Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 2
- KMHSUNDEGHRBNV-UHFFFAOYSA-N 2,4-dichloropyrimidine-5-carbonitrile Chemical compound ClC1=NC=C(C#N)C(Cl)=N1 KMHSUNDEGHRBNV-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- XQXPVVBIMDBYFF-UHFFFAOYSA-N 4-hydroxyphenylacetic acid Chemical compound OC(=O)CC1=CC=C(O)C=C1 XQXPVVBIMDBYFF-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical group C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 239000004721 Polyphenylene oxide Substances 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- RBTKNAXYKSUFRK-UHFFFAOYSA-N heliogen blue Chemical compound [Cu].[N-]1C2=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=NC([N-]1)=C(C=CC=C3)C3=C1N=C([N-]1)C3=CC=CC=C3C1=N2 RBTKNAXYKSUFRK-UHFFFAOYSA-N 0.000 description 2
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- BCHIXGBGRHLSBE-UHFFFAOYSA-N (4-methyl-2-oxochromen-7-yl) dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C=CC2=C1OC(=O)C=C2C BCHIXGBGRHLSBE-UHFFFAOYSA-N 0.000 description 1
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- PCDQPRRSZKQHHS-XVFCMESISA-N CTP Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 PCDQPRRSZKQHHS-XVFCMESISA-N 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102400000113 Calcitonin Human genes 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 239000005046 Chlorosilane Substances 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102400001368 Epidermal growth factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 102400000921 Gastrin Human genes 0.000 description 1
- 108010052343 Gastrins Proteins 0.000 description 1
- 102400000321 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108010004977 Vasopressins Proteins 0.000 description 1
- 102000002852 Vasopressins Human genes 0.000 description 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- AOXOCDRNSPFDPE-UKEONUMOSA-N chembl413654 Chemical compound C([C@H](C(=O)NCC(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](C)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@@H](N)CCC(O)=O)C1=CC=C(O)C=C1 AOXOCDRNSPFDPE-UKEONUMOSA-N 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- USJRLGNYCQWLPF-UHFFFAOYSA-N chlorophosphane Chemical compound ClP USJRLGNYCQWLPF-UHFFFAOYSA-N 0.000 description 1
- DQTRYXANLKJLPK-UHFFFAOYSA-N chlorophosphonous acid Chemical compound OP(O)Cl DQTRYXANLKJLPK-UHFFFAOYSA-N 0.000 description 1
- KOPOQZFJUQMUML-UHFFFAOYSA-N chlorosilane Chemical compound Cl[SiH3] KOPOQZFJUQMUML-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000004956 cyclohexylene group Chemical group 0.000 description 1
- 125000004979 cyclopentylene group Chemical group 0.000 description 1
- 125000004980 cyclopropylene group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 125000005678 ethenylene group Chemical group [H]C([*:1])=C([H])[*:2] 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 229930005303 indole alkaloid Natural products 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 229930013397 isoquinoline alkaloid Natural products 0.000 description 1
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical compound O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- KUHRIIPUCPOQMQ-UHFFFAOYSA-N n,n-diethyl-3-(ethyliminomethylideneamino)propan-1-amine Chemical compound CCN=C=NCCCN(CC)CC KUHRIIPUCPOQMQ-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 125000006410 propenylene group Chemical group 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001174 sulfone group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000002306 tributylsilyl group Chemical group C(CCC)[Si](CCCC)(CCCC)* 0.000 description 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229930004668 tropane alkaloid Natural products 0.000 description 1
- 150000003813 tropane derivatives Chemical class 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 229960003048 vinblastine Drugs 0.000 description 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 description 1
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 1
- 229960004528 vincristine Drugs 0.000 description 1
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、蛍光標識用色素、蛍光
標識用色素で標識された生物由来物質、及びそれらを含
有する試薬に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to fluorescent labeling dyes, biological substances labeled with fluorescent labeling dyes, and reagents containing them.
【0002】0002
【従来の技術】フタロシアニン系顔料は、環状共役鎖を
構成する4つの窒素原子によって結合された4個のイソ
インドール部分を有する有機顔料である。これらの顔料
に用いられている化合物としては、フタロシアニン(青
緑)、銅フタロシアニン(青)、塩素置換銅フタロシア
ニン(緑)、スルホン化銅フタロシアニン(緑)等があ
る。フタロシアニン系顔料は、一般に、エナメル、プラ
スチック、リノリウム、インク、壁紙、織物、紙、ゴム
製品などに使用されている。いっぽう、フリーベースフ
タロシアニン、アルミニウム、カドミウム、マグネシウ
ム、シリコン、すず及び亜鉛フタロシアニンが螢光を示
すことが報告された(ThePhthalocyani
nes 1:127、1983)。BACKGROUND OF THE INVENTION Phthalocyanine pigments are organic pigments having four isoindole moieties linked by four nitrogen atoms constituting a cyclic conjugated chain. Compounds used in these pigments include phthalocyanine (blue-green), copper phthalocyanine (blue), chlorine-substituted copper phthalocyanine (green), and sulfonated copper phthalocyanine (green). Phthalocyanine pigments are commonly used in enamel, plastics, linoleum, inks, wallpaper, textiles, paper, rubber products, etc. On the other hand, it has been reported that free-based phthalocyanines, aluminum, cadmium, magnesium, silicon, tin and zinc phthalocyanines exhibit fluorescence (The Phthalocyanine).
nes 1:127, 1983).
【0003】また、フタロシアニン類は種々の免疫分析
に使用できることが種々報告されている(US特許第4
,160,645号公報、US特許第4,193,98
3号公報、US特許第4,220,450号公報、US
特許第4,233,402号公報、US特許第4,23
5,869号公報、US特許第4,256,834号公
報、US特許第4,277,437号公報、US特許第
4,318,707号公報、US特許第4,483,9
29号公報、US特許第4,540,660号公報、U
S特許第4,540,670号公報、US特許第4,5
60,534号公報、US特許第4,650,770号
公報、US特許第4,656,129号公報、US特許
第4,659,676号公報)。[0003] It has also been reported that phthalocyanines can be used in various immunoassays (US Pat. No. 4
, 160,645, US Pat. No. 4,193,98
Publication No. 3, US Patent No. 4,220,450, US
Patent No. 4,233,402, US Patent No. 4,23
No. 5,869, US Patent No. 4,256,834, US Patent No. 4,277,437, US Patent No. 4,318,707, US Patent No. 4,483,9
No. 29, US Pat. No. 4,540,660, U.
S Patent No. 4,540,670, US Patent No. 4,5
60,534, US Patent No. 4,650,770, US Patent No. 4,656,129, US Patent No. 4,659,676).
【0004】更に、フタロシアニン類は、化学発光免疫
分析系で触媒として使用されている〔Bull.Che
m.Soc.Jpn.第56巻、2965−2968頁
(1983)、同第56巻、2267−2271頁(1
983)、同第57巻、587−588頁(1984)
、同第57巻、3009−3010頁(1984)、同
第58巻、1299−1303頁(1985)〕。原ら
は、ルミノールと過酸化水素とのあいだの化学発光反応
の触媒として鉄フタロシアニンを用いて、化学発光のシ
グナル量から、テストサンプル中の分析対象を定量して
いる。彼らは鉄及びコバルトのフタロシアニン並びに鉄
、パラジウム、白金、マンガン及びスズのポルフィリン
錯体について検討し、鉄フタロシアニンが最も優れた触
媒作用を示し、かつ高感度であることを報告した。Furthermore, phthalocyanines are used as catalysts in chemiluminescent immunoassay systems [Bull. Che
m. Soc. Jpn. Vol. 56, pp. 2965-2968 (1983), Vol. 56, pp. 2267-2271 (1983)
983), Vol. 57, pp. 587-588 (1984)
, Vol. 57, pp. 3009-3010 (1984), Vol. 58, pp. 1299-1303 (1985)]. Hara et al. use iron phthalocyanine as a catalyst for the chemiluminescent reaction between luminol and hydrogen peroxide, and quantify the analyte in the test sample from the amount of chemiluminescent signal. They investigated iron and cobalt phthalocyanines and porphyrin complexes of iron, palladium, platinum, manganese, and tin, and reported that iron phthalocyanine showed the best catalytic activity and high sensitivity.
【0005】免疫分析で着色物質のほかに螢光物質が広
く利用されているが、さらに、酵素免疫分析においても
、螢光物質は感度を上げることができるので着色物質よ
りも好んで使用されるようになってきている。よく知ら
れた螢光物質−酵素対はアルカリホスファターゼ(al
kaline phosphatase)と4−メチ
ルウムベリフェリルホスフェート(4−methylu
mbelliferylphosphate)、β−ガ
ラクトシダーゼ(β−galactosidase)と
4−メチルウムベリフェリル−D−ガラクトピラノシド
(4−methylumbelliferyl−D−g
alactopyranoside)、西洋ワサビのパ
ーオキシダーゼ(horse radish pe
roxidase)とp−ヒドロキシフェニル酢酸(p
−hydroxyphenyl acetic a
cid)等があり、これらの系の検出感度は10−15
Mである。
しかし検出感度をさらに上げようとしても生成する螢光
体の分析特性には限界がある。Fluorescent substances are widely used in addition to colored substances in immunoassays, and fluorescent substances are also preferred over colored substances in enzyme immunoassays because they can increase sensitivity. It's starting to look like this. A well-known fluorophore-enzyme pair is alkaline phosphatase (al
kaline phosphatase) and 4-methylumbelliferyl phosphate (4-methyl
β-galactosidase and 4-methylumbelliferyl-D-galactopyranoside (4-methylumbelliferyl-D-g
horseradish peroxidase (alactopyranoside), horseradish peroxidase
roxidase) and p-hydroxyphenylacetic acid (p
-hydroxyphenyl acetic a
cid), etc., and the detection sensitivity of these systems is 10-15
It is M. However, even if we try to further increase the detection sensitivity, there are limits to the analytical properties of the produced fluorophore.
【0006】最近、螢光量子収率が高く、水に対して高
い溶解性を示すフタロシアニン類を用いた試薬が提案さ
れた(WO特許第88/04777号公報、WO特許第
90/02747号公報、特開平1−233222号公
報)。[0006]Recently, reagents using phthalocyanines that have a high fluorescence quantum yield and high solubility in water have been proposed (WO Patent No. 88/04777, WO Patent No. 90/02747, JP-A-1-233222).
【0007】[0007]
【発明が解決しようとする課題】しかし、フタロシアニ
ン類は吸光係数の特に大きなQ(0,0)吸収帯が65
5〜700nmの領域にあって、650nm以下の波長
域では吸収は比較的に小さい。そのため、600〜65
0nmに発振波長をもつ、半導体レーザを搭載した測定
装置を使用した場合には、検出薬としての優れた役目を
期待できない。[Problems to be Solved by the Invention] However, phthalocyanines have a Q(0,0) absorption band with a particularly large extinction coefficient of 65
In the wavelength range of 5 to 700 nm, absorption is relatively small in the wavelength range of 650 nm or less. Therefore, 600-65
If a measuring device equipped with a semiconductor laser with an oscillation wavelength of 0 nm is used, an excellent role as a detection drug cannot be expected.
【0008】本発明は、650〜700nmに発振波長
をもつ半導体レーザばかりではなく、600〜650n
m付近に発振波長をもつ小型で安価な半導体レーザを用
いても測定できる、種々の抗原、薬物の分析やあるいは
DNAの塩基配列の分析等に有用な試薬又は臨床検査試
薬を提供することを目的とする。The present invention applies not only to semiconductor lasers with an oscillation wavelength of 650 to 700 nm, but also to semiconductor lasers with an oscillation wavelength of 600 to 650 nm.
The purpose of this invention is to provide reagents or clinical test reagents that are useful for the analysis of various antigens and drugs, or the analysis of DNA base sequences, etc., which can be measured using a small and inexpensive semiconductor laser with an oscillation wavelength in the vicinity of m. shall be.
【0009】[0009]
【課題を解決するための手段】本発明は下記(1)〜(
9)に関するものである。すなわち、(1)化2[Means for Solving the Problems] The present invention provides the following (1) to (
9). That is, (1) chemical formula 2
【化2】
〔化2中、Mは、H2 、Al、Si、P、Ga、Ge
、Cd、Sc、Mg、Sn又はZnを示し、R1は、−
XQW、−QW、−W又は水素原子を示し、Xは、酸素
原子、窒素原子、イオウ原子、リン原子、ケイ素原子、
セレン原子、CR2 R3 (ただし、R2 及びR3
は、それぞれ独立に、水素原子、アルキル基、アリー
ル基又はアラルキル基であり、R2 R3 としてカル
ボニル酸素でもよい。)、又はフェニレン基を示し、Q
は、XとWの結合基(リンカー)を示し、Wは−OH、
−O− 、−SH、−S− 、−CO2 H、−CO2
− 、−OCH2 CO2 H、−OCH2 CO2
− 、−PO42 − 、−PO3− 、−SO3−
、 −SO2− 、−SO2 Cl、−SO4
2 − 、−NH2 、−NHR4 、−NR5
R6 又は−N(+)R7R8R9(ただし、R4
〜R9は、それぞれ独立にC1 〜C10のア
ルキル基、C6 〜C12のアリール基又はC6 〜C
12のアラルキル 基である。)であり、nは、
0〜2の整数を示し、Yは、ハロゲン原子、−OR10
又は−NR112 (ただし、R10及びR11は、そ
れぞれ独立に、水素原子、親水性置換基を有するもので
あってもよいアルキル基、親水性置換基を有するもので
あってもよいアシル基、親水性置換基を有するものであ
ってもよいシリル基又は親水性置換基を有するものであ
ってもよいリン原子含有基である。)を示し、mは、Y
のMへの結合数を表わす0〜2の整数を示す。〕で表さ
れる蛍光標識用色素。
(2)上記(1)の蛍光標識用色素を含有する試薬。
(3)上記(1)の蛍光標識用色素で標識された生物由
来物質。
(4)上記(3)の標識された生物由来物質を含有する
試薬。
(5)生物由来物質が抗原、抗体又はヌクレオチドであ
る上記(3)又は(4)の試薬。
(6)抗原が薬物である上記(5)の試薬。
(7)抗体がモノクローナル抗体である上記(5)の試
薬。
(8)ヌクレオチドがオリゴヌクレオチド又はポリヌク
レオチドである(5)の試薬。
(9)ヌクレオチドがATP、CTP、GTP、TTP
、UTP、dATP、dCTP、dGTP、dTTP、
dUTP、ddATP、ddCTP、ddGTP、dd
TTP、ddUTP又はこれらの誘導体である上記(5
)の試薬。[Chemical formula 2] [In chemical formula 2, M is H2, Al, Si, P, Ga, Ge
, Cd, Sc, Mg, Sn or Zn, and R1 is -
XQW, -QW, -W or a hydrogen atom; X is an oxygen atom, a nitrogen atom, a sulfur atom, a phosphorus atom, a silicon atom,
Selenium atom, CR2 R3 (However, R2 and R3
are each independently a hydrogen atom, an alkyl group, an aryl group or an aralkyl group, and R2 R3 may be carbonyl oxygen. ), or a phenylene group, Q
indicates a bonding group (linker) between X and W, W is -OH,
-O-, -SH, -S-, -CO2 H, -CO2
-, -OCH2 CO2 H, -OCH2 CO2
- , -PO42 - , -PO3- , -SO3-
, -SO2- , -SO2 Cl, -SO4
2-, -NH2, -NHR4, -NR5
R6 or -N(+)R7R8R9 (however, R4
~R9 are each independently a C1 to C10 alkyl group, a C6 to C12 aryl group, or a C6 to C12 aryl group
12 aralkyl groups. ), and n is
Indicates an integer of 0 to 2, Y is a halogen atom, -OR10
or -NR112 (However, R10 and R11 each independently represent a hydrogen atom, an alkyl group which may have a hydrophilic substituent, an acyl group which may have a hydrophilic substituent, a hydrophilic is a silyl group which may have a substituent or a phosphorus atom-containing group which may have a hydrophilic substituent), m is Y
An integer from 0 to 2 representing the number of bonds to M. ] Fluorescent labeling dye. (2) A reagent containing the fluorescent labeling dye of (1) above. (3) A biological substance labeled with the fluorescent labeling dye of (1) above. (4) A reagent containing the labeled biological substance of (3) above. (5) The reagent according to (3) or (4) above, wherein the biological substance is an antigen, antibody, or nucleotide. (6) The reagent according to (5) above, wherein the antigen is a drug. (7) The reagent according to (5) above, wherein the antibody is a monoclonal antibody. (8) The reagent according to (5), wherein the nucleotide is an oligonucleotide or a polynucleotide. (9) Nucleotides are ATP, CTP, GTP, TTP
, UTP, dATP, dCTP, dGTP, dTTP,
dUTP, ddATP, ddCTP, ddGTP, dd
The above (5) which is TTP, ddUTP or a derivative thereof
) reagent.
【0010】本発明の化2の化合物において、R1 の
X中のR2 及びR3 のアルキル基の具体例としては
、メチル基、エチル基、プロピル基、sec−プロピル
基、n−ブチル基、iso−ブチル基、t−ブチル基、
ペンチル基、ヘキシル基等があり、アリール基の例とし
ては、フェニル基、チエニル基、フリル基、ピロリル基
、トリル基、アニシル基、4−アミノフェニル基等があ
り、アラルキル基としては、ベンジル基、2−フェニル
エチル基、1−フェニルエチル基、3−フェニルプロピ
ル基、2−フェニルプロピル基、1−フェニルプロピル
基等がある。また、Y中のR10及びR11の親水性置
換基を有するものであってもよいアルキル基の具体例と
しては、メチル基、エチル基、プロピル基、ブチル基、
ペンチル基、ヘキシル基、ヘプチル基、オクチル基、ノ
ニル基、デシル基、ドデシル基、テトラデシル基、ヘキ
サデシル基、オクタデシル基、エイコシル基、ドコシル
基等の直鎖、分枝及び脂環状の基があり、親水性置換基
を有するものであってもよいアシル基の例としては、ホ
ルミル基、アセチル基、プロピオニル基、ブチリル基、
バレリル基、ピバロイル基、ヘキサノイル基、オクタノ
イル基、ラウリル基、パルミチル基、ステアリル基等が
あり、親水性置換基を有するものであってもよいシリル
基としては、トリメチルシリル基、トリエチルシリル基
、トリプロピルシリル基、トリブチルシリル基、トリア
ミルシリル基、トリヘキシルシリル基、t−ブチルジメ
チルシリル基、ジ(t−ブチル)メチルシリル基、ジメ
チルフェニルシリル基、ジフェニルメチルシリル基、ト
リフェニルシリル基等がある。In the compound of formula 2 of the present invention, specific examples of the alkyl groups of R2 and R3 in X of R1 include methyl group, ethyl group, propyl group, sec-propyl group, n-butyl group, iso- butyl group, t-butyl group,
Examples of aryl groups include phenyl group, thienyl group, furyl group, pyrrolyl group, tolyl group, anisyl group, and 4-aminophenyl group; examples of aralkyl groups include benzyl group. , 2-phenylethyl group, 1-phenylethyl group, 3-phenylpropyl group, 2-phenylpropyl group, 1-phenylpropyl group, etc. Further, specific examples of the alkyl group which may have a hydrophilic substituent for R10 and R11 in Y include a methyl group, an ethyl group, a propyl group, a butyl group,
There are straight chain, branched and alicyclic groups such as pentyl group, hexyl group, heptyl group, octyl group, nonyl group, decyl group, dodecyl group, tetradecyl group, hexadecyl group, octadecyl group, eicosyl group, docosyl group, etc. Examples of the acyl group which may have a hydrophilic substituent include formyl group, acetyl group, propionyl group, butyryl group,
Examples include valeryl group, pivaloyl group, hexanoyl group, octanoyl group, lauryl group, palmityl group, stearyl group, etc. Silyl groups that may have hydrophilic substituents include trimethylsilyl group, triethylsilyl group, tripropyl group, etc. Silyl group, tributylsilyl group, triamylsilyl group, trihexylsilyl group, t-butyldimethylsilyl group, di(t-butyl)methylsilyl group, dimethylphenylsilyl group, diphenylmethylsilyl group, triphenylsilyl group, etc. .
【0011】QはXとWを結合する基で、C1〜C8の
飽和又は不飽和の直鎖状、分枝状又は脂環状の結合基、
例えば、メチレン基、エチレン基、トリメチレン基、テ
トラメチレン基、プロピレン基、ビニレン基、プロペニ
レン基、シクロプロピレン基、シクロペンチレン基、シ
クロヘキシレン基等のほか、ポリエーテル、ポリアミン
、ポリアルコール等の基がある。Q is a group that connects X and W, and is a C1 to C8 saturated or unsaturated linear, branched or alicyclic bonding group;
For example, in addition to methylene group, ethylene group, trimethylene group, tetramethylene group, propylene group, vinylene group, propenylene group, cyclopropylene group, cyclopentylene group, cyclohexylene group, etc., groups such as polyether, polyamine, polyalcohol, etc. There is.
【0012】W中、R4 〜R9 のC1〜C10のア
ルキル基としては、メチル基、エチル基、プロピル基、
ブチル基、アミル基、ヘキシル基、ヘプチル基、ノニル
基、デシル基の直鎖状、分枝状及び環状の基があり、C
6〜C12のアリール基としては、フェニル基、トリル
基、アニシル基、ナフチル基、ビフェニル基等があり、
C6〜C12のアラルキル基としては、ベンジル基、2
−フェニルエチル基、1−フェニルエチル基、3−フェ
ニルプロピル基、2−フェニルプロピル基、1−フェニ
ルプロピル基等がある。In W, the C1 to C10 alkyl groups of R4 to R9 include methyl group, ethyl group, propyl group,
There are linear, branched, and cyclic groups such as butyl group, amyl group, hexyl group, heptyl group, nonyl group, and decyl group, and C
Examples of the 6-C12 aryl group include phenyl group, tolyl group, anisyl group, naphthyl group, biphenyl group, etc.
C6 to C12 aralkyl groups include benzyl group, 2
-phenylethyl group, 1-phenylethyl group, 3-phenylpropyl group, 2-phenylpropyl group, 1-phenylpropyl group, etc.
【0013】また、R10及びR11で表されるリン原
子を含む置換基としては、−P(=O)R12R13,
−P(=O)(NR14R15)2 , −PR
162(R12〜R16は、それぞれ独立に、アルキル
基、アリール基、アシル基、シクロアルキル基、アルコ
キシル基、アリールオキシル基、ポリエーテル基、ヒド
ロキシル基又はハロゲン原子を示し、それらは種々の置
換基を持っていてもよい。)がある。[0013] Furthermore, the substituents containing a phosphorus atom represented by R10 and R11 include -P(=O)R12R13,
-P(=O)(NR14R15)2, -PR
162 (R12 to R16 each independently represent an alkyl group, an aryl group, an acyl group, a cycloalkyl group, an alkoxyl group, an aryloxyl group, a polyether group, a hydroxyl group, or a halogen atom, and they can be substituted with various substituents. ).
【0014】化2中、Yが−OR10又は−NR112
(R10及びR11は、アルキル基、アシル基及びシリ
ル基を示す)であり、mが1又は2を表わす化合物は、
化2中、Yが−OH又は−NH2 である化合物を、相
当するアルコール、アシルクロリド、シラノール、クロ
ロシラン、クロロホスフィン、クロロホスファイト又は
ホスフォリルクロリドなどと反応させることによって合
成できる。In formula 2, Y is -OR10 or -NR112
(R10 and R11 represent an alkyl group, an acyl group, and a silyl group), and the compound in which m represents 1 or 2 is:
A compound in which Y is -OH or -NH2 in Chemical Formula 2 can be synthesized by reacting with a corresponding alcohol, acyl chloride, silanol, chlorosilane, chlorophosphine, chlorophosphite, phosphoryl chloride, or the like.
【0015】化2中、Yが−OH又は−NH2 であり
、mが1又は2である化合物は、化2中、Yがハロゲン
原子であり、mが1又は2で表される化合物を加水分解
又は加アンモニア分解することによって得ることができ
る。化2中、Yがハロゲン原子であり、mが1又は2で
表される化合物、及びmがゼロでYをもたない化合物は
、文献〔Inorg. Chem.,第19巻、383
頁(1980年);J. Am. Chem. Soc
., 第112巻、7408頁(1980年);Zh.
Obshch. Khim.,第49巻、 1408
頁(1979年);同、第47巻、2143頁(197
7年);同、第43巻、2025頁(1973年)〕の
方法等を参考にして、次の経路により合成することがで
きる。[0015] The compound in which Y is -OH or -NH2 and m is 1 or 2 in formula 2 is a compound in which Y is a halogen atom and m is 1 or 2 in formula 2. It can be obtained by decomposition or ammoniolysis. Compounds in which Y is a halogen atom and m is 1 or 2 in Chemical Formula 2, and compounds in which m is zero and do not have Y are described in the literature [Inorg. Chem. , Volume 19, 383
Page (1980); J. Am. Chem. Soc.
.. , Vol. 112, p. 7408 (1980); Zh.
Obshch. Khim. , Volume 49, 1408
Page (1979); vol. 47, p. 2143 (197
7); Vol. 43, p. 2025 (1973)], it can be synthesized by the following route.
【0016】すなわち、化3That is, chemical formula 3
【化3】
(化3中、R1及びnは、化2中と同じ意味)で表され
る化合物を、相当する金属又は金属塩と反応させて得る
ことができる。いっぽう、化2中、MがH2 の場合は
、化2中、MがMg又はZnで表される化合物を酸で分
解することにより得ることができる。A compound represented by the following formula (in formula 3, R1 and n have the same meanings as in formula 2) can be obtained by reacting with a corresponding metal or metal salt. On the other hand, when M in Chemical Formula 2 is H2, it can be obtained by decomposing a compound in which M in Chemical Formula 2 is Mg or Zn with an acid.
【0017】本発明において用いられる生物由来物質と
しては、動物、植物、微生物(ウイルスを含む)等の生
物から得られるタンパク質・ペプチド、ヌクレオチド、
糖類、脂質、ホルモン、ビタミン、アルカロイド、抗生
物質、それらの複合物等があり、これらは、天然から抽
出したもの、人工的に完全合成したもの、あるい人工的
に半合成したもののいずれであってもよい。タンパク質
・ペプチドの具体例としては、血清アルブミン、IgG
・IgA・IgM・IgD・IgE等の免疫グロブリン
、種々のタンパク質や白血球の膜抗原に対するモノクロ
ーナル抗体、パーオキシダーゼ、グルコースオキシダー
ゼ、アルカリホスファターゼ等の酵素等が挙げられ、ヌ
クレオチドの具体例としてはDNA、RNA、合成オリ
ゴヌクレオチド、合成ポリヌクレオチド、ATP、CT
P、GTP、TTP、UTP、dATP、dCTP、d
GTP、dTTP、dUTP、ddATP、ddCTP
、ddGTP、ddTTP、ddUTP、あるいはそれ
らの誘導体等が挙げられ、糖類の具体例としては、グリ
コーゲン、デンプン、マンナン等の多糖類のほかオリゴ
糖やグルコース、マンノース等の単糖類が挙げられ、脂
質としては、ホスファチジルコリン、ホスファチジルエ
タノラミン、脂肪、脂肪酸等が挙げられ、ホルモンとし
てはインシュリン、成長ホルモン、オキシトシン、バソ
プレッシン、セクレチン、上皮細胞成長因子、ガストリ
ン、グルカゴン、カルシトニン等のペプチド性ホルモン
、アンドロゲン、エストロゲン、ハイドロコーチゾン等
のステロイドホルモン、アドレナリン、ノルアドレナリ
ン等のカテコラミン類等が挙げられ、ビタミンとしては
ビタミンA、ビタミンB1、B2、B6、B12、ビオ
チン、葉酸、ビタミンC、ビタミンD、ビタミンE等の
各種ビタミンが挙げられ、アルカロイドとしてはモルフ
ィン等のアヘンアルカロイド、アトロピン、スコポラミ
ン等のトロパンアルカロイド、ビンブラスチン、ビンク
リスチン等のインドールアルカロイド、オウレン等のイ
ソキノリンアルカロイド等が挙げられ、抗生物質として
は、ペニシリン、セファロスポリン、カナマイシン、エ
リスロマイシン、クロラムフェニコール等が挙げられる
。[0017] The biological substances used in the present invention include proteins, peptides, nucleotides, etc. obtained from living organisms such as animals, plants, and microorganisms (including viruses).
There are sugars, lipids, hormones, vitamins, alkaloids, antibiotics, and complexes thereof, and these may be extracted from nature, completely synthetically synthesized, or semi-synthesized artificially. You can. Specific examples of proteins/peptides include serum albumin, IgG
- Immunoglobulins such as IgA, IgM, IgD, and IgE, monoclonal antibodies against various proteins and leukocyte membrane antigens, enzymes such as peroxidase, glucose oxidase, and alkaline phosphatase, etc., and specific examples of nucleotides include DNA and RNA. , synthetic oligonucleotide, synthetic polynucleotide, ATP, CT
P, GTP, TTP, UTP, dATP, dCTP, d
GTP, dTTP, dUTP, ddATP, ddCTP
, ddGTP, ddTTP, ddUTP, or derivatives thereof. Specific examples of saccharides include polysaccharides such as glycogen, starch, and mannan, as well as monosaccharides such as oligosaccharides, glucose, and mannose; Examples include phosphatidylcholine, phosphatidylethanolamine, fats, fatty acids, etc. Hormones include insulin, growth hormone, oxytocin, vasopressin, secretin, epidermal growth factor, gastrin, glucagon, peptide hormones such as calcitonin, androgens, estrogens, Examples include steroid hormones such as hydrocortisone, catecholamines such as adrenaline and noradrenaline, and various vitamins such as vitamin A, vitamin B1, B2, B6, B12, biotin, folic acid, vitamin C, vitamin D, and vitamin E. Examples of alkaloids include opium alkaloids such as morphine, tropane alkaloids such as atropine and scopolamine, indole alkaloids such as vinblastine and vincristine, and isoquinoline alkaloids such as ouren. Examples of antibiotics include penicillin, cephalosporin, Examples include kanamycin, erythromycin, chloramphenicol, and the like.
【0018】生物由来物質に蛍光標識用色素を結合させ
るためには、生物由来物質中のアミノ基、水酸基等の官
能基と蛍光標識用色素中のカルボキシル基、スルフォン
基等の官能基を利用して直接、イオン結合的又は共有結
合的に直接結合させるか、あるいは蛍光標識用色素が反
応できるように、生物由来物質の一部に結合基(リンカ
ー)を付加する等の化学修飾を施したのち、反応させれ
ばよい。蛍光標識用色素で標識された生物由来物質はク
ロマトグラフィー、再結晶等の慣用の分離手段により精
製することができる。[0018] In order to bond a fluorescent labeling dye to a biological substance, the functional groups such as amino groups and hydroxyl groups in the biological substance and the carboxyl group and sulfone group in the fluorescent labeling dye are used. directly, ionic or covalently bonded, or after chemical modification such as adding a binding group (linker) to a part of the biological material so that the fluorescent labeling dye can react with it. , just react. A biological substance labeled with a fluorescent labeling dye can be purified by conventional separation means such as chromatography and recrystallization.
【0019】化2で表される化合物のQ(0,0)吸収
帯は、R1で示される置換基を変化させることによって
、フタロシアニン類の吸収領域と同じ領域ばかりではな
く、それよりも短波長域(600〜650nm)に移動
するので、そのことを利用して、化2で表される化合物
は600〜720nmに発振波長をもつどの半導体レー
ザを用いた場合も、種々の抗原、薬物の分析やあるいは
DNAの塩基配列の分析等に有用な、精度の高い試薬又
は臨床検査試薬として利用されうる。By changing the substituent represented by R1, the Q(0,0) absorption band of the compound represented by formula 2 is not only in the same region as the absorption region of phthalocyanines, but also has a wavelength shorter than that. Using this fact, the compound represented by chemical formula 2 can be used to analyze various antigens and drugs using any semiconductor laser with an oscillation wavelength of 600 to 720 nm. It can also be used as a highly accurate reagent or clinical test reagent useful for DNA base sequence analysis.
【0020】[0020]
【実施例】以下、実施例により更に具体的に本発明を説
明する。
実施例 1
(1)化2中、MがH2、R1が4−ヒドロキシカルボ
ニルベンジルチオ基、nが2、mが0でYのない化合物
の合成
文献〔J. Am. Chem. Soc., 第11
2巻、7408頁(1990年)〕記載の方法を参考に
して、化2中、MがH2、R1が4−ヒドロキシカルボ
ニルベンジルチオ基、nが2、mが0でYのない化合物
を合成した。EXAMPLES The present invention will now be explained in more detail with reference to Examples. Example 1 (1) In chemical formula 2, M is H2, R1 is a 4-hydroxycarbonylbenzylthio group, n is 2, m is 0, and there is no Y, synthesis literature [J. Am. Chem. Soc. , 11th
2, p. 7408 (1990)], synthesized a compound in which M is H2, R1 is a 4-hydroxycarbonylbenzylthio group, n is 2, m is 0, and there is no Y. did.
【0021】(2)リンカーが結合したオリゴヌクレオ
チド・プライマーの合成
固相CED−フォスフォラミド法を用いた自動DNA合
成装置によりプライマー(5’−GTTTCCCAGT
CACGAC−3’)を合成した。合成したプライマー
のリン酸化は、50mMトリス−塩酸(pH7.6)、
10mM塩化マグネシウム、10mMジチオスレイトー
ル、3mM ATP、T4−ヌクレオチドカイネースを
含む100μlの反応液中で37℃、1時間保温して行
った。リン酸化されたプライマーは、ゲル濾過用カラム
を使用して高速液体クロマトグラフィー(HPLC)で
分離し、リン酸化されたプライマーのピークを集め、凍
結乾燥で溶媒を除いた。次に、これを250mMの1,
2−ジアミノエタン(pH6.0),200mMのエチ
ル−3(3−ジエチルアミノプロピル)カルボジイミド
及び100mMのN−メチルイミダゾール(pH6.0
)を含む反応液100μl中、25℃で一晩保温して5
’末端のグアノシンのリン酸部にリンカー〔NH2−(
CH2)2−NH−〕を結合させた。(2) Synthesis of linker-bound oligonucleotide primer The primer (5'-GTTTCCCAGT
CACGAC-3') was synthesized. Phosphorylation of the synthesized primers was carried out using 50mM Tris-HCl (pH 7.6),
The reaction was carried out in a 100 μl reaction solution containing 10 mM magnesium chloride, 10 mM dithiothreitol, 3 mM ATP, and T4-nucleotide kinase at 37° C. for 1 hour. The phosphorylated primer was separated by high performance liquid chromatography (HPLC) using a gel filtration column, the peak of the phosphorylated primer was collected, and the solvent was removed by lyophilization. Next, this was mixed with 250mM of 1,
2-diaminoethane (pH 6.0), 200 mM ethyl-3(3-diethylaminopropyl)carbodiimide and 100 mM N-methylimidazole (pH 6.0).
) in 100 μl of a reaction solution containing
' A linker [NH2-(
CH2)2-NH-] was combined.
【0022】(3)化2中、MがH2、R1が4−ヒド
ロキシカルボニルベンジルチオ基、nが2、mが0でY
のない化合物によって標識されたオリゴヌクレオチド・
プライマーの合成
上記(1)で合成した化合物と上記(2)で合成した5
’末端グアノシンのリン酸部にリンカーが結合したオリ
ゴヌクレオチド・プライマーを、0.2M炭酸ナトリウ
ム緩衝液(pH9.3)中で混合し、25℃で一晩、暗
所に保温したのち、HPLCで精製することにより、リ
ンカーを介して化2中、MがH2、R1が4−ヒドロキ
シカルボニルベンジルチオ基、nが2、mが0でYのな
い化合物の結合したプライマーを得た。(3) In formula 2, M is H2, R1 is a 4-hydroxycarbonylbenzylthio group, n is 2, m is 0, and Y
Oligonucleotides labeled with compounds without
Synthesis of primers The compound synthesized in (1) above and 5 synthesized in (2) above
'An oligonucleotide primer with a linker attached to the phosphate moiety of the terminal guanosine was mixed in 0.2M sodium carbonate buffer (pH 9.3), incubated overnight at 25°C in the dark, and then analyzed by HPLC. By purification, a primer was obtained in which a compound of formula 2 in which M is H2, R1 is a 4-hydroxycarbonylbenzylthio group, n is 2, m is 0, and there is no Y is bound via a linker.
【0023】(4)DNAの塩基配列の分析リンカーを
介して化2中、MがH2、R1が4−ヒドロキシカルボ
ニルベンジルチオ基、nが2、mが0でYのない化合物
の結合したプライマーを用いて、既知の塩基配列のDN
Aをサンプルとして、それぞれ4種の塩基でサンガー反
応を行ったのち、それぞれ別々のレーンで電気泳動分離
し、670nmの発振波長の半導体レーザーを搭載した
DNAシークエンサーで分析した。その結果、DNAの
310塩基までを99%の精度で決定できた。(4) DNA base sequence analysis A primer to which a compound of formula 2, where M is H2, R1 is a 4-hydroxycarbonylbenzylthio group, n is 2, m is 0, and there is no Y, is bound via a linker. DN of the known base sequence using
Using A as a sample, each sample was subjected to Sanger reaction with four types of bases, separated by electrophoresis in separate lanes, and analyzed using a DNA sequencer equipped with a semiconductor laser with an oscillation wavelength of 670 nm. As a result, up to 310 bases of DNA could be determined with 99% accuracy.
【0024】実施例2
文献〔J. Am. Chem. Soc., 第11
2巻、7408頁(1990年)〕記載の方法を参考に
して、化2中、MがAl、R1が4−スルフォベンジル
チオ基、nが2、mが0でYのない化合物を合成した。
以下、実施例1と同様に操作して、リンカーを介してこ
の化合物が結合したプライマーを得、これを用いて、既
知の塩基配列のDNAを分析した結果、DNAの370
塩基までを99%の精度で決定できた。Example 2 Reference [J. Am. Chem. Soc. , 11th
2, page 7408 (1990)], synthesized a compound in which M is Al, R1 is a 4-sulfobenzylthio group, n is 2, m is 0, and there is no Y. did. Hereinafter, in the same manner as in Example 1, a primer to which this compound was bound via a linker was obtained, and DNA with a known base sequence was analyzed using this primer. As a result, 370
Even bases could be determined with 99% accuracy.
【0025】実施例3
文献〔Zh. Obshch. Khim.,第43巻
、2025頁(1973年)〕記載の方法を参考にして
、化2中、MがZn、R1が4−ヒドロキシカルボニル
フェニル基、nが2、mが0でYのない化合物を合成し
たのち、実施例1と同様に操作して、リンカーを介して
この化合物が結合したプライマーを得た。次に、これを
用いて、610nmに発振波長をもつレーザ光(N2レ
ーザ−色素レーザの組み合わせによる)によって、既知
の塩基配列のDNAを分析した結果、DNAの270塩
基までを99%の精度で決定できた。Example 3 Literature [Zh. Obshch. Khim. , Vol. 43, p. 2025 (1973)], a compound in which M is Zn, R1 is a 4-hydroxycarbonylphenyl group, n is 2, m is 0, and there is no Y is prepared. After the synthesis, the same procedure as in Example 1 was carried out to obtain a primer to which this compound was bound via a linker. Next, using this, we analyzed DNA with known base sequences using a laser beam with an oscillation wavelength of 610 nm (based on a combination of N2 laser and dye laser). As a result, up to 270 bases of DNA were analyzed with 99% accuracy. I was able to decide.
【0026】実施例4
文献〔Zh. Obshch. Khim.,第43巻
、2025頁(1973年)〕記載の方法を参考にして
、化2中、MがAl、R1がスルフォフェニル基、nが
2、mが0でYのない化合物を合成した。以下、実施例
3と同様に操作して、リンカーを介してこの化合物が結
合したプライマーを得、これを用いて、既知の塩基配列
のDNAを分析した結果、DNAの350塩基までを9
9%の精度で決定できた。Example 4 Literature [Zh. Obshch. Khim. , Vol. 43, p. 2025 (1973)], a compound in which M is Al, R1 is a sulfophenyl group, n is 2, m is 0, and there is no Y was synthesized. . Hereinafter, in the same manner as in Example 3, a primer to which this compound was bound via a linker was obtained, and DNA with a known base sequence was analyzed using this primer. As a result, up to 350 bases of DNA were
It was determined with an accuracy of 9%.
【0027】[0027]
【発明の効果】本発明により、600〜720nmに発
振波長をもつ半導体レーザを用いて測定するための、種
々の抗原、薬物あるいはDNAの塩基配列等の分析に有
用な試薬又は臨床検査試薬を提供できた。Effects of the Invention The present invention provides reagents or clinical test reagents useful for analyzing various antigens, drugs, DNA base sequences, etc., which are measured using a semiconductor laser with an oscillation wavelength of 600 to 720 nm. did it.
Claims (9)
、Cd、Sc、Mg、Sn又はZnを示し、R1は、−
XQW、−QW、−W又は水素原子を示し、Xは、酸素
原子、窒素原子、イオウ原子、リン原子、ケイ素原子、
セレン原子、CR2 R3 (ただし、R2 及びR3
は、それぞれ独立に、水素原子、アルキル基、アリー
ル基又はアラルキル基であり、R2 R3 としてカル
ボニル酸素でもよい。)、又はフェニレン基を示し、Q
は、XとWの結合基(リンカー)を示し、Wは−OH、
−O− 、−SH、−S− 、−CO2 H、−CO2
− 、−OCH2 CO2 H、−OCH2 CO2
− 、−PO42 − 、−PO3− 、−SO3−
、 −SO2− 、−SO2 Cl、−SO4
2 − 、−NH2 、−NHR4 、−NR5
R6 又は−N(+)R7R8R9(ただし、R4
〜R9は、それぞれ独立にC1 〜C10のア
ルキル基、C6 〜C12のアリール基又はC6 〜C
12のアラルキル 基である。)であり、nは、
0〜2の整数を示し、Yは、ハロゲン原子、−OR10
又は−NR112 (ただし、R10及びR11は、そ
れぞれ独立に、水素原子、親水性置換基を有するもので
あってもよいアルキル基、親水性置換基を有するもので
あってもよいアシル基、親水性置換基を有するものであ
ってもよいシリル基又は親水性置換基を有するものであ
ってもよいリン原子含有基である。)を示し、mは、Y
のMへの結合数を表わす0〜2の整数を示す。〕で表さ
れる蛍光標識用色素。Claim 1: Chemical formula 1 [Chemical formula 1] [In chemical formula 1, M is H2, Al, Si, P, Ga, Ge
, Cd, Sc, Mg, Sn or Zn, and R1 is -
XQW, -QW, -W or a hydrogen atom; X is an oxygen atom, a nitrogen atom, a sulfur atom, a phosphorus atom, a silicon atom,
Selenium atom, CR2 R3 (However, R2 and R3
are each independently a hydrogen atom, an alkyl group, an aryl group or an aralkyl group, and R2 R3 may be carbonyl oxygen. ), or a phenylene group, Q
indicates a bonding group (linker) between X and W, W is -OH,
-O-, -SH, -S-, -CO2 H, -CO2
-, -OCH2 CO2 H, -OCH2 CO2
- , -PO42 - , -PO3- , -SO3-
, -SO2- , -SO2 Cl, -SO4
2-, -NH2, -NHR4, -NR5
R6 or -N(+)R7R8R9 (however, R4
~R9 are each independently a C1 to C10 alkyl group, a C6 to C12 aryl group, or a C6 to C12 aryl group
12 aralkyl groups. ), and n is
Indicates an integer of 0 to 2, Y is a halogen atom, -OR10
or -NR112 (However, R10 and R11 each independently represent a hydrogen atom, an alkyl group which may have a hydrophilic substituent, an acyl group which may have a hydrophilic substituent, a hydrophilic is a silyl group which may have a substituent or a phosphorus atom-containing group which may have a hydrophilic substituent), m is Y
An integer from 0 to 2 representing the number of bonds to M. ] Fluorescent labeling dye.
試薬。2. A reagent containing the fluorescent labeling dye according to claim 1.
た生物由来物質。3. A biological substance labeled with the fluorescent labeling dye according to claim 1.
含有する試薬。4. A reagent containing the labeled biological substance according to claim 3.
ドである請求項3又は請求項4記載の試薬。5. The reagent according to claim 3 or 4, wherein the biological substance is an antigen, an antibody, or a nucleotide.
記載の試薬。Claim 7: Claim 5 wherein the antibody is a monoclonal antibody.
Reagents listed.
リヌクレオチドである請求項5記載の試薬。8. The reagent according to claim 5, wherein the nucleotide is an oligonucleotide or a polynucleotide.
TTP、UTP、dATP、dCTP、dGTP、dT
TP、dUTP、ddATP、ddCTP、ddGTP
、ddTTP、ddUTP又はこれらの誘導体である請
求項5記載の試薬。Claim 9: The nucleotide is ATP, CTP, GTP,
TTP, UTP, dATP, dCTP, dGTP, dT
TP, dUTP, ddATP, ddCTP, ddGTP
, ddTTP, ddUTP or a derivative thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12437291A JPH04351961A (en) | 1991-05-29 | 1991-05-29 | Fluorescent label-coloring matter, organism-derived material labeled tereby and reagent containing these |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12437291A JPH04351961A (en) | 1991-05-29 | 1991-05-29 | Fluorescent label-coloring matter, organism-derived material labeled tereby and reagent containing these |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04351961A true JPH04351961A (en) | 1992-12-07 |
Family
ID=14883772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12437291A Pending JPH04351961A (en) | 1991-05-29 | 1991-05-29 | Fluorescent label-coloring matter, organism-derived material labeled tereby and reagent containing these |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04351961A (en) |
-
1991
- 1991-05-29 JP JP12437291A patent/JPH04351961A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4898951A (en) | Compounds used as intermediates in the preparations of non-radioactive biological probes | |
US6582930B1 (en) | Porphyrin compounds, their conjugates and assay methods based on the use of said conjugates | |
US5198537A (en) | Digoxigenin derivatives and use thereof | |
EP0747706B1 (en) | Adduct protection assay | |
US20050130207A1 (en) | Small organometallic probes | |
EP0502723B1 (en) | Water-soluble tetraazaporphins and fluorochrome for labeling | |
JP2002529466A5 (en) | ||
EP0518930A1 (en) | Cyclodextrin compositions and methods for pharmaceutical and industrial applications | |
EP0597389B1 (en) | Water-soluble tetraazaporphins and fluorochrome for labeling | |
JP2604993B2 (en) | New biotinylation reagent | |
US8389298B2 (en) | Methods using novel chemiluminescent labels | |
JP4098839B2 (en) | Indocyanine compounds | |
Warme et al. | Heme sulfuric anhydrides. I. Synthesis and reactions of mesoheme sulfuric anhydride | |
JPH10509731A (en) | Phosphatase-activated crosslinker, binder and reducing agent and methods of use thereof, and phosphatase-activated crosslinker and reagent containing binder | |
JPH05287209A (en) | Fluorescent labelling dye, biogenic substance labelled with the same, and reagent containing them | |
EP0155854B1 (en) | Non-radioactive biological probes | |
JPH04351961A (en) | Fluorescent label-coloring matter, organism-derived material labeled tereby and reagent containing these | |
JPH04351960A (en) | Fluorescent label-coloring matter, organism-derived material labeled tereby and reagent containing these | |
JP2964761B2 (en) | Novel water-soluble tetraazaporphine, a fluorescent labeling dye containing the same, a biological substance labeled with the fluorescent labeling dye, a reagent containing the same, and a fluorescence analysis method using the same | |
JPH04344464A (en) | Fluorescent labeling pigment, biogenic material labeled by fluorescent labeling pigment and reagent coating them | |
JPH05194942A (en) | Fluorescent marking pigment, biogenous substance marked with fluorescent marking pigment, and reagent containing them | |
AU737441B2 (en) | Trans-platinum compound, and diagnostic kit | |
JPH0540121A (en) | Pigment for fluorescence labeling, organism-derived substance labeled with pigment for fluorescence labeling and reagent containing them | |
JPH04320456A (en) | Pigment for fluorescent labeling, bio substance labeled therewith, and reagent containing the same | |
JPH05107188A (en) | Pigment for luorescent labeling, boisubstance labeled by same and reagent containing the pigment and substance |